Atossa Therapeutics annual gross margin
2011
2012
2013
2014
2015
Atossa Therapeutics's gross margin was −7,431.91% for fiscal 2015.
View full Atossa Therapeutics company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2015 | 2015-12-31 | −7,431.91% | −7531.91 pp |
| 2014 | 2014-12-31 | 100.00% | +78.33 pp |
| 2013 | 2013-12-31 | 21.67% | −64.71 pp |
| 2012 | 2012-12-31 | 86.38% | +6465.71 pp |
| 2011 | 2011-12-31 | −6,379.33% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2015 | 2015-12-31 | −33,531.91% | −33631.91 pp |
| Q4 2014 | 2014-12-31 | 100.00% | +383.16 pp |
| Q3 2014 | 2014-09-30 | 100.00% | +33.86 pp |
| Q2 2014 | 2014-06-30 | 100.00% | +68.13 pp |
| Q1 2014 | 2014-03-31 | 100.00% | +36.38 pp |
| Q4 2013 | 2013-12-31 | −283.16% | −377.31 pp |
| Q3 2013 | 2013-09-30 | 66.14% | −19.58 pp |
| Q2 2013 | 2013-06-30 | 31.87% | −60.16 pp |
| Q1 2013 | 2013-03-31 | 63.62% | +12.97 pp |
| Q4 2012 | 2012-12-31 | 94.15% | — |
| Q3 2012 | 2012-09-30 | 85.72% | — |
| Q2 2012 | 2012-06-30 | 92.03% | — |
| Q1 2012 | 2012-03-31 | 50.64% | — |
Across the available reported history, Atossa Therapeutics's gross margin decreased from 100.00% to −7,431.91%, a change of −7531.91 percentage points. The latest reported quarter, Q4 2015, shows −33,531.91%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Atossa Therapeutics filings at SEC.gov ↗